Pretagostini R, Peritore D, Rizzato L, Stabile D, D'Alessandro F, Michelangeli G, Vespasiano F, Costa A Nanni
Interregional Transplant Centre, Organizzazione Centro Sud Trapianti, Surgery Sciences Department of Policlinico of Rome, Umberto I, Rome, Italy.
Transplant Proc. 2013 Sep;45(7):2607-9. doi: 10.1016/j.transproceed.2013.08.008.
An urgent lung transplantation national program in Italy was developed over the past three years. Indispensable conditions that were included in the program were invasive respiratory support and/or extracorporeal vascular device (DECAP excluded). The aim of this study was to test the effectiveness of the program.
We analyzed urgent lung requests received between 2009 and 2011 taking into account primary pathology, request outcome, average waiting time, and organ origin. Taking as reference the same period of time, we also examined the ordinary waiting list, waiting list mortality, and number of transplantations performed and we have compared them with another three-year period prior to the activation of the program.
The total number of urgent requests was 43. Primary pathologies with the highest incidence proportion were cystic fibrosis (40%) and idiopathic pulmonary fibrosis (26.6%). A total of 34 requests (79%) were successfully dealt with and 9 of them were suspended because of worsening conditions. The average waiting time was 17.9 days. During the same period of time 340 lung transplantations were performed and there were 499, 524, and 564 wait-listed patients in 2009, 2010, and 2011, respectively. The mortality rate was 21.3%. Over the previous three-year period 295 transplantations were performed and there were 457, 476, and 464 wait-listed patients in 2006, 2007, and 2008, respectively. Also the mortality rate was 25.3%.
Urgent lung transplantations can provide patients in an imminent life-threatening situation with adequate care without affecting the mortality rate of patients on the ordinary waiting list.
在过去三年中,意大利制定了一项紧急肺移植国家计划。该计划包含的必要条件为有创呼吸支持和/或体外血管装置(不包括体外膜肺氧合)。本研究的目的是测试该计划的有效性。
我们分析了2009年至2011年期间收到的紧急肺移植申请,考虑了原发性病理、申请结果、平均等待时间和器官来源。以同一时间段为参照,我们还检查了普通等待名单、等待名单上的死亡率以及进行的移植手术数量,并将它们与该计划启动前的另一个三年期进行了比较。
紧急申请总数为43例。发病率比例最高的原发性病理为囊性纤维化(40%)和特发性肺纤维化(26.6%)。共有34例申请(79%)得到成功处理,其中9例因病情恶化而暂停。平均等待时间为17.9天。在同一时期,进行了340例肺移植手术,2009年、2010年和2011年分别有499例、524例和564例患者在等待名单上。死亡率为21.3%。在前一个三年期,进行了295例移植手术,2006年、2007年和2008年分别有457例、476例和464例患者在等待名单上。死亡率也为25.3%。
紧急肺移植可以为处于危及生命紧急状况的患者提供充分治疗,而不影响普通等待名单上患者的死亡率。